Search - tctmd.com

Displaying 1 - 20 of 40

Sort: Relevancy | Date

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Michael O'Riordan

January 22, 2025

News Conference News NY Valves 2024

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

Michael O'Riordan

June 12, 2024

News Conference News ESC Heart Failure 2024

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Michael O'Riordan

May 13, 2024

News Conference News ACC 2024

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Michael O'Riordan

April 06, 2024

News Conference News THT 2024

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Michael O'Riordan

March 08, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

News Conference News THT 2024

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

Michael O'Riordan

March 06, 2024

News Daily News

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

L.A. McKeown

February 12, 2024

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HCM3

News Conference News AHA 2023

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

Shelley Wood

November 11, 2023

News Conference News HFSA 2023

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

Todd Neale

October 11, 2023

News ESC 2023

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Michael O'Riordan

August 27, 2023

News Daily News

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Michael O'Riordan

August 10, 2023

News Daily News

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

Shelley Wood

July 19, 2023

News Conference News TVT 2023

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

Michael O'Riordan

June 12, 2023

News Daily News

One in Six COAPT Patients Had Malnutrition: TEER Helped Regardless

Shelley Wood

June 12, 2023

News Conference News TVT 2023

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Shelley Wood

June 09, 2023

News Daily News

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Michael O'Riordan

March 29, 2023

News Conference News THT 2023

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

Todd Neale

March 22, 2023

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

Advertisement

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Benefits of Various SGLT2 Inhibitors Mostly Consistent in Observational Study

Polymer Mitral Valve Shows Well Early, but Long-term Data Key

SEQUOIA-HCM: Aficamten Boosts Exercise Capacity in Obstructive HCM

Interatrial Shunt Falls Short in Sham-Controlled RELIEVE-HF

Small Study Hints at Potential for HF Bone Marrow Cell Therapy: CardiAMP-HF

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Durable 1-Year Outcomes With Coronary Sinus Shunt for HF: ALT-FLOW EFS

More Mortality Reduction Signals With Implantable Hemodynamic Monitors in HFrEF: Meta-analysis

Dropping Aspirin Cuts Strokes, Bleeds, Hospital Stays in LVAD Patients: ARIES-HM3

REBALANCE-HF Uncovers HFpEF Group That Responds to Splanchnic Nerve Ablation

Qiliqiangxin, a Traditional Chinese Medication, Cuts CV Events in HF: QUEST

Cardiosave IABPs Recalled Again, This Time Due to Potential Electrical Problems: FDA

Takotsubo Trigger Type Matters, With Physical Shocks Linked to Worse Outcomes

No-Implant Shunt for HF Looks Safe, Feasible in Early Snapshot

One in Six COAPT Patients Had Malnutrition: TEER Helped Regardless

Latest-Generation MitraClip Devices Make Strides Against Residual MR

Poor Outcomes in HF Patients With Moderate Aortic Stenosis: Observational Data

Preliminary Results Suggest Benefit of Splanchnic Nerve Ablation in HFpEF

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content